Search research articles
Contact Us
Filters
Showing results (51-60 of 191) with videos related to
Page
of 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers
Raffit Hassan, Steven J Cohen, Martin Phillips, et al.
JAMA Oncology
|
October 9, 2025
Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility
Lauren E Merz, Yating Wang, Angel Cronin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2011
Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts
Miriam E Mossoba, Masanori Onda, Justin Taylor, et al.
The Oncologist
|
August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Clinical and Translational Gastroenterology
|
April 7, 2026
Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and Complications
Matthew J Townsend, Afeerah Mumtaz, Jordan S Sack, et al.
The Plant Journal : for Cell and Molecular Biology
|
April 10, 2021
Spatial patterning of scent in petunia corolla is discriminated by bees and involves the ABCG1 transporter
Oded Skaliter, Yaarit Kitsberg, Elad Sharon, et al.
Cancer
|
July 4, 2014
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125
Raffit Hassan, Elad Sharon, Anish Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2017
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity
Valsamo Anagnostou, Mark Yarchoan, Aaron R Hansen, et al.
American Journal of Hematology
|
March 14, 2022
Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma
Andrew M Evens, Justin S Brandt, Cody J Peer, et al.
Clinical Chemistry and Laboratory Medicine
|
December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
Elad Sharon, Jingli Zhang, Kevin Hollevoet, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 191) with videos related to
Sort By:
Page
of 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers
Raffit Hassan, Steven J Cohen, Martin Phillips, et al.
JAMA Oncology
|
October 9, 2025
Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility
Lauren E Merz, Yating Wang, Angel Cronin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2011
Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts
Miriam E Mossoba, Masanori Onda, Justin Taylor, et al.
The Oncologist
|
August 16, 2021
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, et al.
Clinical and Translational Gastroenterology
|
April 7, 2026
Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and Complications
Matthew J Townsend, Afeerah Mumtaz, Jordan S Sack, et al.
The Plant Journal : for Cell and Molecular Biology
|
April 10, 2021
Spatial patterning of scent in petunia corolla is discriminated by bees and involves the ABCG1 transporter
Oded Skaliter, Yaarit Kitsberg, Elad Sharon, et al.
Cancer
|
July 4, 2014
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125
Raffit Hassan, Elad Sharon, Anish Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2017
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity
Valsamo Anagnostou, Mark Yarchoan, Aaron R Hansen, et al.
American Journal of Hematology
|
March 14, 2022
Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma
Andrew M Evens, Justin S Brandt, Cody J Peer, et al.
Clinical Chemistry and Laboratory Medicine
|
December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
Elad Sharon, Jingli Zhang, Kevin Hollevoet, et al.
Page
of 20